Search

everythinglearnresearchcommunity

for

Search:↓

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Oral tranexamic acid is a safe and effective treatment for melasma.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Therapy lowers IgM levels in dogs with severe dermatitis but not in mild cases.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Human skin can make serotonin and melatonin.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Improving skin barrier and using antifungal treatments can help manage dandruff.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Future acne treatments should aggressively target inflammation to prevent scarring.

FFA's causes may include environmental triggers and genetic factors.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.